May 10,2021

Use and Accuracy of Inpatient CGM During the COVID-19 Pandemic: An Observational Study of General Medicine and ICU Patients

Continuous glucose monitoring (CGM) is widely used in the outpatient setting for people with diabetes and has been limited to investigational use only for the inpatient population. In April 2020, the US FDA exercised enforcement discretion for the temporary use of inpatient CGM during the pandemic, thus hospitals were presented the opportunity to implement this technology.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
May 10,2021

UK healthtech pioneer my mhealth announces successful roll-out of NHS-approved diabetes app to the community of Kent

Largest ever roll-out of a diabetes digital therapeutic programme deemed a success for granting 100,000 people in Kent access to cutting-edge technology.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 11,2021

Mashantucket Pequot Tribal Nation’s Partnership with Virta Health Shows Progress

Today, Virta Health announced one-year patient outcomes from its multi-year partnership with Mashantucket Pequot Tribal Nation, with promising results in A1c reduction, weight loss, and insulin de-prescription. Notably, at one year of the Virta Treatment, Pequot patients reduced their insulin prescriptions by 78%. These outcomes also drove significant cost savings—at two years, the tribe’s spend on diabetes-specific medications decreased by 72%. 

PRODUCT

#coaching

View Analyst & Ambassador Comments
Go to original news
May 12,2021

Improving Glycemic Control in Type 2 Diabetes Using Mobile Applications and e-Coaching: A Mixed Treatment Comparison Network Meta-Analysis

This study compared the effectiveness of glycemic control among usual care, care management using a mobile application (app), and management using an app with additional e-coaching for patients with type 2 diabetes mellitus (T2DM) using a mixed treatment comparison (MTC) network meta-analysis (NMA)

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 12,2021

Digital Connectivity: The Sixth Vital Sign

Digital health and telehealth connectivity have become important aspects of clinical care. Connected devices, including continuous glucose monitors and automated insulin delivery systems for diabetes, are being used increasingly to support personalized clinical decisions based on automatically collected data. Furthermore, the development, demand, and coverage for telehealth have all recently expanded, as a result of the COVID-19 pandemic.

CLINICAL STUDY

#telehealth

View Analyst & Ambassador Comments
Go to original news
May 12,2021

Brighter Reports First Quarter Interim Report January – March 2021

Brighter AB [publ], today has published first quarter interim report for January – March 2021. The full report is available on the company website https://brighter.se. The report is also attached to this press release as a pdf file.

View Analyst & Ambassador Comments
Go to original news
May 12,2021

Indigo Diabetes Appoints Paul Moraviec as Chairman of the Board

Indigo Diabetes Appoints Paul Moraviec as Chairman of the Board by Indigo, NewsWe are pleased to announce the appointment of Paul Moraviec as Chairman of our Board of Directors Paul Moraviec – Brings decades of leadership experience in the Global MedTech sector – As CEO of ConvaTec Group Plc, led the $5 billion IPO on the London...

View Analyst & Ambassador Comments
Go to original news
Dec 29,2020

Humana rolls out virtual diabetes program for Kentucky Medicaid patients

Digital health startup Vida Health struck its first partnership with a Medicaid plan. Humana will offer Vida’s virtual diabetes management program to its Medicaid members in Kentucky starting next year. Vida’s programs offer access to health coaches and licensed therapists. It also has an app that users can link with a connected scale, glucometer and fitness tracker.

COLLABORATION PARTNERSHIP

#insurance

#coaching

View Analyst & Ambassador Comments
Go to original news
May 14,2021

One Drop Receives CE Mark for AI-Powered Blood Glucose Forecasts

Powered by nearly 25 billion health data points, One Drop’s CE-marked glucose predictions enable people living with chronic conditions to be proactive about their health

REGULATORY FDA

#cgm

View Analyst & Ambassador Comments
Go to original news
May 17,2021

Brighter Makes Progress with the User Experience Test of the Diabetes Management Solution Actiste

Brighter AB [publ], today announced the User Experience collaboration with two Swedish health centers, one in Halland and the other in Västra Götaland, is making progress. Brighter´s senior diabetes nurse Lisa Malm shares her observations from onboarded patients.

PRODUCT

#insulin pen

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES